entertainment -WSS

entertainment

author：leisure time 2025-10-02 01:07:56 - browse：36

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： PhRMA lawsuit over Medicare drug price negotiation tossed

WSS

Medicare Advantage proposed rates disappoint insurers

Private equity deals in Medicare Advantage declines

Australia’s approach to dialysis celebrates life

CDC advisory panel says seniors 'may' get RSV vaccine

Why did Pfizer dish out millions for a Super Bowl ad?

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

entertainment

entertainment

entertainment

Medical leaders decry Supreme Court decision on affirmative action

CDC advisory panel says seniors 'may' get RSV vaccine

Virginia high school admissions case could be legal follow

'Revelatory' study finds a smoking impact that remains after quitting

Drug repurposing or repositioning? The language matters

Departing Stanford president retracts two papers

After affirmative action ruling, medical educators look to 'holistic review'

How to make Best Hospitals ratings actually useful for patients

Virginia high school admissions case could be legal follow

Apellis safety probe of eye disease drug centers on injection needle

entertainment

2024 GOP presidential candidates spar over abortion in debate

Psilocybin's anti

Vaccine advisory panel ACIP left half staffed by HHS

Neuroscience startup Neumora files for IPO

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Feds fine Medicare Advantage plans for overcharging members

explore

hotspot

leisure time

Wikipedia